Cargando…
Effect of interleukin-1 antagonist on growth of children with colchicine resistant or intolerant FMF
INTRODUCTION: Familial Mediterranean Fever (FMF) is the most common monogentic autoinflammatory disease. FMF results from mutations in MEFV, which lead to a pro-inflammatory state and increased production of Interleukin 1 beta subunit (IL-1b) by myeloid cells. Despite the overall positive results ob...
Autores principales: | Pinchevski-Kadir, Shiran, Gerstein, Maya, Pleniceanu, Oren, Yacobi, Yonatan, Vivante, Asaf, Granat, Ortal Erez, Spielman, Shiri, Oz, Rotem Semo, Tirosh, Irit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827626/ https://www.ncbi.nlm.nih.gov/pubmed/36624531 http://dx.doi.org/10.1186/s12969-022-00784-6 |
Ejemplares similares
-
Colchicine treatment can be discontinued in a selected group of pediatric FMF patients
por: Cohen, Keren, et al.
Publicado: (2023) -
Colchicine intolerance in FMF patients and primary obstacles for optimal dosing
por: SATIŞ, Hasan, et al.
Publicado: (2020) -
Colchicine therapy in children with FMF
por: Knieper, A-M, et al.
Publicado: (2015) -
Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients
por: Salehzadeh, Farhad, et al.
Publicado: (2019) -
The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine resistant or intolerant FMF
por: Hashkes, P, et al.
Publicado: (2015)